COMP <GO>
ECG vs TSLA // DIVIDEND YIELD & FCF PAYOUT SAFETY
Everus Construction Group Inc. (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: ECG 8
— TSLA 6
■ METRIC PARITY
LAST: $102.63 (-5.02%) • MKT CAP: $5.52B
dividend-safety
0.00%
LAST: $399.81 (-0.87%) • MKT CAP: $1.58T
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 19.29% | -7.19 | TSLA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 3.39% | +27.01 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 199.0x | -185.34 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 0.21% | -0.42 | TSLA | /fcf-yield <GO> |
| Operating Margin | 7.10% | 3.35% | +3.75 | ECG | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 3.11% | +2.29 | ECG | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 8.30% | +23.20 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 15.35 | -8.88 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | ECG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 8.72% | -1.42 | ECG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 60.9 | -20.55 | TSLA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.89 | -0.76 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 174.4x | -151.53 | ECG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.52B | $1.58T | -$1.57T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | TSLA REV | ECG GROSS % | TSLA GROSS % | ECG FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $94.83B | 12.1% | 18.0% | -$11.7M | $6.22B |
| FY 2024 | $2.85B | $97.69B | 11.9% | 17.9% | $35.1M | $3.58B |
| FY 2023 | $2.85B | $96.77B | 44.0% | 18.3% | $42.9M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
TSLA // BETA 1.89